Tian-Ao Xie

Tian-Ao Xie

Auto-generated profile, based on publicly available information

Tian-Ao Xie

Department of Clinical Medicine, The Third Clinical School of Guangzhou Medical University, Guangzhou, 511436, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2023 in Immunotherapy
Verified
Journal Article
Closed access
XZXueyin Zhou
Xueyin Zhou
JCJiasheng Cao
Jiasheng Cao
WTWin Topatana
Win Topatana
TXTianao Xie
Tianao Xie
TCTianen Chen
Tianen Chen
MCMingyu Chen
Mingyu Chen
Aim: To determine if PD-L1 can be used as a biomarker to predict the efficacy of anti-PD-1/PD-L1 inhibitors in hepatocellular carcinoma (HCC). Methods: Relevant studies from a specific search of th... Plain language summary Clinically, liver cancer patients with high PD-L1 levels may not benefit from immunotherapy. Conversely, some patients with low PD-L1 level can benefit from it. Therefore, th...

1 January 2022 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
PHPei-Ying Huang
Pei-Ying Huang
XYXin Yin
Xin Yin
YHYue-Ting Huang
Yue-Ting Huang
QYQi-Qing Ye
Qi-Qing Ye
SCSi-Qing Chen
Si-Qing Chen
XGXu-Guang Guo
Xu-Guang Guo
Huang PY, et al. Yonsei Med J. 2022 May;63(5):480-489. https://doi.org/10.3349/ymj.2022.63.5.480

1 January 2022 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
LXLi-Min Xie
Li-Min Xie
XYXin Yin
Xin Yin
TXTian-Ao Xie
Tian-Ao Xie
JSJian-Wen Su
Jian-Wen Su
QHQin Huang
Qin Huang
XGXu-Guang Guo
Xu-Guang Guo
Xie LM, et al. Yonsei Med J. 2022 Jan;63(1):95-103. https://doi.org/10.3349/ymj.2022.63.1.95